Sevlaren 400 Tablet is a medication used to treat high phosphate levels in the blood. It is primarily prescribed to patients undergoing dialysis due to severe kidney disease. By inhibiting the absorption of phosphate from the intestines, Sevlaren 400 Tablet helps lower phosphate levels in the bloodstream. This medication belongs to a group of medicines known as phosphate binders.

Sevlaren 400 Tablet should be taken with food as directed by your doctor. It is essential to take the medication consistently at the same time each day to maximize its benefits. However, there are potential side effects associated with Sevlaren 400 Tablet, such as nausea, vomiting, abdominal pain, constipation, and diarrhea. In some cases, it may also lead to decreased levels of calcium, folic acid, and various vitamins in the blood. Patients are advised to take necessary supplements as recommended by their healthcare provider.

The active ingredient in Sevlaren-400 Tablet 10's is sevelamer, which effectively binds phosphate in the gastrointestinal tract, reducing its absorption into the bloodstream. This mechanism helps regulate phosphate levels in the body, preventing the accumulation of excess phosphate and promoting bone health. Patients on dialysis or with chronic kidney disease can benefit from Sevlaren-400 Tablet 10's in managing high phosphate levels and reducing the risk of associated complications like heart disease and strokes.

It is important to follow your doctor's instructions precisely when taking Sevlaren-400 Tablet 10's. Common side effects of this medication may include vomiting, abdominal pain, nausea, diarrhea, stomach ache, and indigestion. Patients should promptly consult their healthcare provider if these side effects persist or worsen. Notably, individuals with known allergies to the components of the medication, low phosphate levels, or bowel obstruction should avoid using Sevlaren-400 Tablet 10's.

SEVLAREN 400MG TABLET, containing Sevelamer as the active ingredient, falls under the category of Phosphate Binding Agents. It is primarily indicated in patients with chronic kidney disease requiring dialysis to control serum phosphorus levels. Regular monitoring and adherence to dietary recommendations are crucial during treatment with SEVLAREN 400MG TABLET to prevent adverse effects.

Patients with low phosphorus levels in the blood or bowel obstructions should avoid using SEVLAREN 400MG TABLET. Special caution is advised for individuals experiencing swallowing difficulties, stomach and bowel motility issues, or those with a history of major bowel surgeries. Pregnant or breastfeeding women should consult with their healthcare provider before starting SEVLAREN 400MG TABLET to assess potential risks and benefits for themselves and their baby.

In summary, Sevlaren 400 Tablet and its variants are essential medications for managing high phosphate levels in patients with kidney disease undergoing dialysis. Adherence to dosing instructions, monitoring for side effects, and consulting healthcare providers are vital aspects of using these medications effectively and safely.